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in this volume of Cell Cycle, Ling et al. discov-
ered acetylation-based control of centrosome 
duplication and amplification.1 The centro-
some is primarily recognized as a microtu-
bule-organizing center (MTOC), capable of 
nucleating and anchoring microtubules. At 
the G1/S transition of the cell cycle, centro-
some duplication is initiated, and by G2/M, the 
process is complete. Normally, vertebrate cen-
trosomes duplicate once and only once during 
the cell cycle and contribute to the formation 
of the two spindle poles during mitosis.
Aberrant centrosome duplication can 
result in centrosome amplification, a condi-
tion found in many cancers. This can lead to 
multipolar spindles and, in turn, chromosome 
segregation errors, loss of tumor suppres-
sor function and aggressive malignancies.2,3 
Centrosome duplication must be tightly con-
trolled to prevent centrosome amplification 
and to couple it with DNA replication.
Several mechanisms can contribute to cen-
trosome/MTOC amplification in tumor cells, 
including cytokinetic failure, centrosome over-
duplication, centriole pair splitting and acentri-
olar MTOC formation.2,4 Certain tumor-derived 
cell lines undergo multiple rounds of centro-
some duplication when DNA replication is 
blocked, delaying S phase.2 Centrosome dupli-
cation is under cell cycle regulator control, 
which controls DNA replication and thereby 
coordinates the two events. Phosphorylation 
also contributes to centrosome duplication, 
but little is known about the role of other post-
translational modifications in this process.1 in 
this study by Ling et al., the authors addressed 
this question. They unexpectedly found that 
centrosome number is controlled by deacety-
lases in both normal and tumor cells.
Histone acetylation is a common form of 
acetylation, but non-histone acetylation is also 
significant and plays a major role in mRNA 
and protein stability, protein interactions and 
protein localization.5 in this study, the authors 
unexpectedly found that several centrosome 
proteins are acetylated (centrin, Plk2 and SEPT7). 
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They also made the surprising discovery that 
several deacetylases localize to centrosomes 
(8/18) and suppress centrosome amplification 
following expression above endogenous levels 
(7/8). in contrast, only 3/10 non-centrosomal 
deacetylases suppressed centrosome ampli-
fication, suggesting a role for acetylation/ 
deacetylation in centrosome number control.
The authors next identified a subset of 
deacetylases with the highest centrosome 
amplification suppression activity (HDAC1, 
HDAC5, SiRT1). They showed that the deacety-
lase activity of HDAC1 and SiRT1 was required 
to suppress centrosome amplification, but not 
for HDAC5. in contrast, HDAC5 phosphoryla-
tion was required for suppression activity, sug-
gesting that posttranslational events localize 
HDAC5 to centrosomes suppressing centro-
some amplification. More work is required 
to understand this differential localization, as 
well as the mechanism of deacetylase action, 
possible links to the cell cycle and how deacet-
ylases are regulated.
in a previous study, Fukasawa et al. found 
that cyclin A was required for centrosome re-
duplication in cells arrested in late S/G2 phase.
6 
Here, they found that HDAC1 overexpression 
suppressed cyclin A transcription.1 Following 
completion of centrosome duplication, we 
speculate that the centrosomal localization 
of HDAC1 suppresses cyclin A expression, or 
that low cyclin A levels permit centrosome 
localization of HDAC1. Consistent with this 
model is a previous study showing that HDAC1 
localizes to centrosomes in metaphase7 when 
centrosomes are not replicating and cyclin A 
expression is low.
Does this work have significance for the 
etiology of cancer and in therapeutic strate-
gies? Centrosome amplification has become a 
hallmark of carcinomas and other cancers. The 
finding that many deacetylases suppress cen-
trosome amplification is inconsistent with the 
described increase in deacetylase expression 
in cancer cells.8 Moreover, deacetylase inhibi-
tors have anticancer effects.8 However, it is 
unclear if the deacetylase inhibitors used in the 
cancer studies affect deacetylase localization 
to centrosomes. Additional studies will shed 
light on the roles of deacetylases/acetylases in 
centrosome duplication and amplification. For 
example, it is likely that these enzymes func-
tion in duplication control, but they could also 
participate in the many steps of centrosome 
assembly that have been uncovered over the 
last several years.9
This paper provides novel insights into 
regulation of centrosome duplication/ampli-
fication through the identification of new 
contributors to this process, acetylases/
deacetylases. Moreover, the discovery of acet-
ylated centrosome proteins establishes new 
frontiers to understanding how post-trans-
lational modifications regulate centrosome 
function. Based on the profound changes in 
centrosome numbers induced by the pertur-
bation of deacetylases, it is clear that this new 
area of centrosome biology has high potential 
to yield important insights into centrosome 
duplication and, perhaps, into other aspects of 
centrosome biology for years to come.
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